Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration.

MLA

Matsumoto, Hidetaka, et al. “Efficacy of Treat-and-Extend Regimen with Aflibercept for Pachychoroid Neovasculopathy and Type 1 Neovascular Age-Related Macular Degeneration.” Japanese Journal of Ophthalmology, vol. 62, no. 2, Mar. 2018, pp. 144–50. EBSCOhost, https://doi.org/10.1007/s10384-018-0562-0.

APA

Matsumoto, H., Hiroe, T., Morimoto, M., Mimura, K., Ito, A., & Akiyama, H. (2018). Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration. Japanese Journal of Ophthalmology, 62(2), 144–150. https://doi.org/10.1007/s10384-018-0562-0

Chicago

Matsumoto, Hidetaka, Takashi Hiroe, Masahiro Morimoto, Kensuke Mimura, Arisa Ito, and Hideo Akiyama. 2018. “Efficacy of Treat-and-Extend Regimen with Aflibercept for Pachychoroid Neovasculopathy and Type 1 Neovascular Age-Related Macular Degeneration.” Japanese Journal of Ophthalmology 62 (2): 144–50. doi:10.1007/s10384-018-0562-0.